New retinal imaging techniques to help treat memory loss in Alzheimer's patients

Novel Early Retinal Imaging Biomarkers for Treating Later Spatial Memory Loss in Experimental Alzheimer's Disease

['FUNDING_R01'] · WAYNE STATE UNIVERSITY · NIH-11114012

This study is looking at how changes in the eye can help spot early signs of memory loss in people with Alzheimer's, aiming to find new ways to help improve thinking skills before major problems arise.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorWAYNE STATE UNIVERSITY (nih funded)
Locations1 site (DETROIT, UNITED STATES)
Trial IDNIH-11114012 on ClinicalTrials.gov

What this research studies

This research investigates how early changes in the retina can serve as biomarkers for cognitive decline in Alzheimer's disease. By examining the retina, which shows similar damage to the brain, researchers aim to identify signs of Alzheimer's before significant cognitive impairment occurs. The study will explore the relationship between retinal health and memory loss, potentially using innovative imaging techniques to assess these changes. This approach could lead to new treatment strategies that focus on restoring cognitive function without necessarily targeting amyloid plaques.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease or those in the early stages of cognitive decline.

Not a fit: Patients with advanced Alzheimer's disease or those without any cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and more effective treatments for memory loss in Alzheimer's patients.

How similar studies have performed: Previous research has shown promise in using retinal biomarkers to assess cognitive decline, suggesting that this approach could be a viable method for early intervention.

Where this research is happening

DETROIT, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.